|
|
Volumn 27, Issue 34, 2009, Pages
|
|
Impact on cardiac toxicity with trastuzumab and radiotherapy: The question is still ongoing
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
TRASTUZUMAB;
ANTINEOPLASTIC AGENT;
MONOCLONAL ANTIBODY;
CANCER MORTALITY;
CANCER RADIOTHERAPY;
CARDIOTOXICITY;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
FOLLOW UP;
HEART LEFT VENTRICLE EJECTION FRACTION;
HUMAN;
LETTER;
PHASE 3 CLINICAL TRIAL;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL;
RETROSPECTIVE STUDY;
BREAST TUMOR;
DRUG EFFECT;
FEMALE;
HEART;
NOTE;
RADIATION EXPOSURE;
RADIATION INJURY;
ANTIBODIES, MONOCLONAL;
ANTINEOPLASTIC AGENTS;
BREAST NEOPLASMS;
FEMALE;
HEART;
HUMANS;
RADIATION INJURIES;
|
|
EID: 73349118154
PISSN: 0732183X
EISSN: None
Source Type: Journal
DOI: 10.1200/JCO.2009.24.6918 Document Type: Letter |
|
Times cited : (11)
|
|
References (4)
|
